APA

Fournier E., Inchiappa L., Delattre C., Pignon J., Danicourt F., Bemba M., Roche-Lestienne C., Daudignon A., Decool G., Roumier C., Dumezy F., Fournier L., Grardel N., Preudhomme C. & Duployez N. (20200728). Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in. : Leukemia & lymphoma.

Chicago

Fournier Elise, Inchiappa Luca, Delattre Carole, Pignon Jean-Michel, Danicourt Frédérique, Bemba Maxime, Roche-Lestienne Catherine, Daudignon Agnès, Decool Gauthier, Roumier Christophe, Dumezy Florent, Fournier Loïc, Grardel Nathalie, Preudhomme Claude and Duployez Nicolas. 20200728. Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in. : Leukemia & lymphoma.

Harvard

Fournier E., Inchiappa L., Delattre C., Pignon J., Danicourt F., Bemba M., Roche-Lestienne C., Daudignon A., Decool G., Roumier C., Dumezy F., Fournier L., Grardel N., Preudhomme C. and Duployez N. (20200728). Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in. : Leukemia & lymphoma.

MLA

Fournier Elise, Inchiappa Luca, Delattre Carole, Pignon Jean-Michel, Danicourt Frédérique, Bemba Maxime, Roche-Lestienne Catherine, Daudignon Agnès, Decool Gauthier, Roumier Christophe, Dumezy Florent, Fournier Loïc, Grardel Nathalie, Preudhomme Claude and Duployez Nicolas. Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in. : Leukemia & lymphoma. 20200728.